Your browser doesn't support javascript.
Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers.
McFadden, David D; Bornstein, Shari L; Vassallo, Robert; Salonen, Bradley R; Bhuiyan, Mohammed Nadir; Schroeder, Darrell R; Croghan, Ivana T.
  • McFadden DD; Mayo Clinic, Rochester, MN, USA.
  • Bornstein SL; Mayo Clinic, Rochester, MN, USA.
  • Vassallo R; Mayo Clinic, Rochester, MN, USA.
  • Salonen BR; Mayo Clinic, Rochester, MN, USA.
  • Bhuiyan MN; Mayo Clinic, Rochester, MN, USA.
  • Schroeder DR; Mayo Clinic, Rochester, MN, USA.
  • Croghan IT; Mayo Clinic, Rochester, MN, USA.
J Prim Care Community Health ; 13: 21501319211062672, 2022.
Article in English | MEDLINE | ID: covidwho-1606513
ABSTRACT

OBJECTIVES:

The purpose of the present study was to assess and describe the severity of symptoms reported by Covid-19 positive patients who vaped (smoked e-cigarettes) when compared to those who did not vape or smoke at the time of the diagnosis of Covid-19.

METHODS:

Patients from this study are from a well-characterized patient cohort collected at Mayo Clinic between March 1, 2020 and February 28, 2021; with confirmed COVID-19 diagnosis defined as a positive result on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays from nasopharyngeal swab specimens. Among the 1734 eligible patients, 289 patients reported current vaping. The cohort of vapers (N = 289) was age and gender matched to 1445 covid-19 positive patients who did not vape. The data analyzed included date of birth, gender, ethnicity, race, marital status, as well as lifestyle history such as vaping and smoking and reported covid-19 symptoms experienced.

RESULTS:

A logistic regression analysis was performed separately for each symptom using generalized estimating equations (GEE) with robust variance estimates in order to account for the 15 age, sex, and race matched set study design. Patients who vaped and developed Covid-19 infection were more likely to have chest pain or tightness (16% vs 10%, vapers vs non vapers, P = .005), chills (25% vs 19%, vapers vs non vapers, P = .0016), myalgia (39% vs 32%, vapers vs non vapers, P = .004), headaches (49% vs 41% vapers vs non vapers, P = .026), anosmia/dysgeusia (37% vs 30%, vapers vs non vapers, P = .009), nausea/vomiting/abdominal pain (16% vs 10%, vapers vs non vapers, P = .003), diarrhea (16% vs 10%, vapers vs non vapers, P = .004), and non-severe light-headedness (16% vs 9%, vapers vs non vapers, P < .001).

CONCLUSION:

Vapers experience higher frequency of covid-19 related symptoms when compared with age and gender matched non-vapers. Further work should examine the impact vaping has on post-covid symptom experience.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Electronic Nicotine Delivery Systems / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Prim Care Community Health Year: 2022 Document Type: Article Affiliation country: 21501319211062672

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Electronic Nicotine Delivery Systems / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Prim Care Community Health Year: 2022 Document Type: Article Affiliation country: 21501319211062672